Trial Profile
Phase I/II Trial of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Dec 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Adverse reactions
- Sponsors Taiwan Liposome Company
- 05 Jan 2021 Status changed from active, no longer recruiting to completed.
- 26 May 2020 Status changed from recruiting to active, no longer recruiting.
- 10 Mar 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.